Skip to main content
Clinical Trials/NCT07412912
NCT07412912Not yet recruitingNot Applicable

Optimizing Implementation of the Intensive Diabetes Prevention Program in District Health Centres: A Hybrid Type 3 Study to Enhance Recruitment and Retention for Prediabetes Management

The Hong Kong Polytechnic University0 sites170 target enrollmentStarted: June 1, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
170
Primary Endpoint
Recruitment rate

Study Overview

Brief Summary

The goal of this clinical trial is to explore the effectiveness and implementation outcomes of the optimized Intensive Diabetes Prevention Program (IDPP) in District Health Centres. The main questions it aims to answer are:

  • Do the implementation strategies - patient engagement system, structured training, and reminder systems - work better than usual approaches in terms of acceptability, adoption, appropriateness, feasibility, sustainability, and implementation cost?
  • Do patient health outcomes - HbA1c levels, BMI, lipid profile, quality of life, perception of empowerment, and health service utilization - stay the same or get better when these improved strategies are used compared to usual approaches?

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Double (Participant, Outcomes Assessor)

Masking Description

The research team staff and participants will be masked for the group allocation during the whole process.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Being 18 years of age or above
  • Having a baseline HbA1c within the prediabetes range (6.0%-6.4%)
  • Holding a scheduled appointment at a DHC

Exclusion Criteria

  • Having a diagnosis of diabetes mellitus
  • Currently using of oral hypoglycaemic agents or medications known to induce significant weight changes
  • Having medical conditions that would limit participation, such as active cancer or cognitive impairment

Arms & Interventions

Control group

Active Comparator

Participants in the control group will receive the standard IDPP as routinely delivered by the DHCs, without additional engagement or implementation strategies. This includes up to four optional group education sessions, two annual nurse-led consultations, and up to three individual counselling sessions per year.

Intervention: Standard IDPP (Behavioral)

Intervention group

Experimental

The intervention group will follow the same one-year IDPP structure as the control group, but will experience a series of optimized implementation strategies including adding pre-implementation staff training, two enhanced nurse consultations, a structured reminder and follow-up system, and sustainment strategies.

Intervention: Optimized IDPP (Behavioral)

Outcomes

Primary Outcomes

Recruitment rate

Time Frame: One year

Recruitment rate will be defined as the proportion of eligible individuals at participating DHCs who are successfully recruited into the study.

Retention rate

Time Frame: One year

Retention rate will be defined as the percentage of enrolled participants who complete both scheduled nurse-led consultations and attend at least two of the four group education sessions within the 12-month intervention period.

Acceptability

Time Frame: One year

Acceptability will be assessed through semi-structured focus group interviews with participants and providers after the implementation phase. Participants will share their satisfaction with key program components, and discuss perceived benefits and challenges. Providers will reflect on the practicality and relevance of the training sessions and enhanced workflows, and how these strategies affected their ability to deliver the IDPP effectively.

Participant adherence

Time Frame: One year

Participant adherence will be measured using attendance records from nurse consultations and group workshops.

Provider adherence

Time Frame: One year

Provider adherence will be assessed through meeting logs and fidelity checklists that capture consistent application of optimized protocols in clinical practice.

Appropriateness

Time Frame: One year

Appropriateness will be evaluated through semi-structured interviews with key stakeholders, including DHC managers, nurses, dietitians, physiotherapists, and participants. Interviews will explore how well the optimized implementation strategies fit within existing DHC workflows, address operational challenges, and support patient engagement.

Fidelity

Time Frame: One year

Fidelity, defined as the extent to which implementation strategies are delivered consistently and as intended, will be assessed using structured performance checklists completed by the PI during random audits of nurse consultations, along with reviews of audio-recorded sessions and provider self-reported logs.

Implementation cost

Time Frame: One year

Implementation cost will be assessed from an organizational perspective by capturing direct costs associated with delivering the optimized IDPP. Data will include staff time and operational expenses, with incremental cost-effectiveness analyses conducted alongside sensitivity analyses to test key cost assumptions; results will be presented using cost-effectiveness planes and bootstrapped confidence intervals.

Sustainability

Time Frame: 1.5 years

Sustainability will be evaluated by examining the extent to which optimized strategies remain embedded in routine DHC operations after external research support concludes. Focus groups with DHC managers and nurses at the end of the sustainment phase will explore long-term feasibility, while metrics will assess continued use of optimized workflows, provider adherence to protocols, and sustained patient engagement.

Secondary Outcomes

  • Changes in HbA1c(Baseline, six months, one year, 1.5 years)
  • Lipid profile(Baseline, six months, one year, 1.5 years)
  • Weight(Baseline, six months, one year, 1.5 years)
  • Height(Baseline, six months, one year, 1.5 years)
  • Perceptions of empowerment(Baseline, six months, one year, 1.5 years)
  • Quality of Life (QoL)(Baseline, six months, one year, 1.5 years)
  • Health service utilization(Baseline, six months, one year, 1.5 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Arkers, Wong

Associate Professor

The Hong Kong Polytechnic University

Similar Trials